Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03697083 · ClinicalTrials.gov registry record · NA
Reminders Through Association & Prescription Adherence
A NA study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- NA
- Development phase
- 777
- Enrollment target
NCT03697083: Clinical Trial NA study, sponsored by University of Pennsylvania.
NCT03697083 is a NA study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 777 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03697083, a NA study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- NA
- Development phase
- 777 participants
- Enrollment target
Study Summary
The purpose of this study is to develop behavioral interventions that provide effective tools that policy makers can use to help individuals avoid forgetting to follow-through on important behaviors and for individuals to use to help themselves. In the investigators past research, they have shown that reminders through association work in the lab setting. The investigators seek to understand how this strategy can work in the field, especially when people are trying to fulfill a health outcome.
Primary Outcome
At the beginning of the study, participants indicate the date they plan to pick up their prescription. Participants are later asked to text a picture of their prescription receipt to the experimenter after they complete the prescription reminder program. The receipt must satisfy three criteria: 1. The receipt must show that a prescription was purchased. 2. The receipt must show the date of purchase. This date of purchase must match the participant's intended pick up date. 3. The participant mus
Interventions
- OTHER Active Control
- OTHER Reminders Through Association
- OTHER Baseline Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 777 participants |
| Start Date | 2018-06-14 |
| Est. Completion | 2018-09-21 |
| Phase | NA |
Why NCT03697083 stopped before completion
NCT03697083 is an interventional study that assigns participants to a tested intervention. The registered 777 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% lower).
The record links to 0 conditions, and to 3 interventions - of which Active Control is the first listed.
NCT03697083 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03697083 about?
NCT03697083 is a clinical study titled "Reminders Through Association & Prescription Adherence". The purpose of this study is to develop behavioral interventions that provide effective tools that policy makers can use to help individuals avoid forgetting to follow-through on important behaviors and for individuals to use to help themselves. In the investigators past research, they have shown th...
What is the current status of trial NCT03697083?
This trial is currently terminated. It is a NA study. The enrollment target is 777 participants. The study started on 2018-06-14. Estimated completion is 2018-09-21.
What interventions are being tested in trial NCT03697083?
The interventions under investigation include: Active Control (OTHER), Reminders Through Association (OTHER), Baseline Control (OTHER).
Who is sponsoring clinical trial NCT03697083?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03697083's enrollment target sits among peer trials
777 142nd of 2000 higher than 1,859 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05642611 · 777 participants · Phase 3
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
- NCT06841679 · 778 participants · Phase 2
Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT06145763 · 776 participants · NA
A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial
- NCT03460769 · 775 participants
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI